BIOMARKERS

  • N Epsilon-(Hexanoyl) lysine, a new oxidative stress marker, is increased in metabolic syndrome, but not in obstructive sleep apnea.
    (Tokuda F, et al. Am J Med Sci. 2009 Aug;338(2):127-33.)
    View Abstract
  • Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.
    (Ooi EM, et al. Diabetes Res Clin Pract. 2009 Sep;85(3):310-6. Epub 2009 Jul 1.)
    View Abstract
  • Multiple biomarkers and their relative contributions to identifying metabolic syndrome.
    (Lee JG, et al. Clin Chim Acta. 2009 Jul 19. [Epub ahead of print])
    View Abstract
  • Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.
    (Saleem U, et al. J Clin Endocrinol Metab. 2009 Jul;94(7):2558-64. Epub 2009 Apr 14.)
    View Abstract

CANCER

  • A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.
    (Kabat GC, et al. Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2046-53. Epub 2009 Jun 30.)
    View Abstract
  • Metabolic syndrome and risk of cancer mortality in men.
    (Jaggers JR, et al. Eur J Cancer. 2009 Jul;45(10):1831-8. Epub 2009 Feb 26.)
    View Abstract
  • Racial differences in risk of prostate cancer associated with metabolic syndrome.
    (Beebe-Dimmer JL, et al. Urology. 2009 Jul;74(1):185-90. Epub 2009 May 9.)
    View Abstract

CARDIOVASCULAR DISEASE / CARDIAC FUNCTION

  • Influence of the metabolic syndrome versus the sum of its individual components on left ventricular geometry in young adults (from the Bogalusa Heart Study).
    (Patel DA, et al. Am J Cardiol. 2009 Jul 1;104(1):69-73.)
    View Abstract
  • Correlation of normal diastolic cardiac function with VO in the metabolic syndrome.
    (Chockalingam A, et al. Prev Cardiol. 2009 Summer;12(3):163-8.)
    View Abstract
  • Cardiorespiratory fitness and the metabolic syndrome in firefighters.
    (Donovan R, et al. Occup Med (Lond). 2009 Jul 3. [Epub ahead of print])
    View Abstract
  • Impact of the metabolic syndrome on aortic pulse pressure and ascending aortic pulsatility in patients with angiographically normal coronary arteries.
    (Emre A, et al. Can J Cardiol. 2009 Jul;25(7):411-4.)
    View Abstract
  • Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome.
    (Grassi G, et al. Prog Cardiovasc Dis. 2009 Jul-Aug;52(1):31-7. Review.)
    View Abstract
  • eNOS, metabolic syndrome and cardiovascular disease.
    (Huang PL. Trends Endocrinol Metab. 2009 Aug;20(6):295-302. Epub 2009 Jul 31.)
    View Abstract
  • Circulating IL-8 levels in heart failure patients with and without metabolic syndrome.
    (Shin MJ, et al. Clin Chim Acta. 2009 Jul;405(1-2):139-42. Epub 2009 May 3.)
    View Abstract
  • Metabolic syndrome predicts lower functional recovery in female but not in male patients after an acute cardiac event.
    (Caminiti G, et al. Int J Cardiol. 2009 Jul 10;135(3):296-301. Epub 2008 Jul 7.)
    View Abstract
  • N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index.
    (Sezen Y, et al. Clin Biochem. 2009 Jul 16. [Epub ahead of print])
    View Abstract
  • Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance.
    (Wada H, et al. Atherosclerosis. 2009 Jul 30. [Epub ahead of print])
    View Abstract

DEFINING THE METABOLIC SYNDROME

  • Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    (Boronat M, et al. Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):417-22. Epub 2008 Sep 25.)
    View Abstract
  • Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO.
    (Ma WY, et al. Diabetes Res Clin Pract. 2009 Sep;85(3):335-41. Epub 2009 Jul 16.)
    View Abstract

DIABETES

  • Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome?
    (Aslan Y, et al. Urology. 2009 Jul 13. [Epub ahead of print])
    View Abstract
  • Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes.
    (Chillarón JJ, et al. J Clin Endocrinol Metab. 2009 Jul 7. [Epub ahead of print])
    View Abstract
  • Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men.
    (Church TS, et al. Diabetes Care. 2009 Jul;32(7):1289-94. Epub 2009 Apr 14.)
    View Abstract
  • Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes.
    (Clausen TD, et al. J Clin Endocrinol Metab. 2009 Jul;94(7):2464-70. Epub 2009 May 5.)
    View Abstract
  • 52-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycaemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.
    (Heufelder AE, et al. J Androl. 2009 Jul 3. [Epub ahead of print])
    View Abstract
  • The influence of insulin pump treatment on metabolic syndrome parameters in type 2 diabetes mellitus.
    (Jankovec Z, et al. Wien Klin Wochenschr. 2009 Jul;121(13-14):459-463.)
    View Abstract
  • Association of FVC and total mortality in US adults with metabolic syndrome and diabetes.
    (Lee HM, et al. Chest. 2009 Jul;136(1):171-6. Epub 2009 May 8.)
    View Abstract
  • The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women.
    (Oda E, et al. Intern Med. 2009;48(13):1127-34. Epub 2009 Jul 1.)
    View Abstract

DIET, NUTRITION, AND METABOLISM

  • Carbohydrate restriction, as a first-line dietary intervention, effectively reduces biomarkers of metabolic syndrome in emirati adults.
    (Al-Sarraj T, et al. J Nutr. 2009 Sep;139(9):1667-76. Epub 2009 Jul 8.)
    View Abstract
  • Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome.
    (Fessler MB, et al. Curr Opin Lipidol. 2009 Jul 21. [Epub ahead of print])
    View Abstract
  • Adherence to the Mediterranean diet moderates the association of aminotransferases with the prevalence of the metabolic syndrome; the ATTICA study.
    (Tzima N, et al. Nutr Metab (Lond). 2009 Jul 30;6:30.)
    View Abstract
  • Metabolic syndrome and serum carotenoids: findings of a cross-sectional study in Queensland, Australia.
    (Coyne T, et al. Br J Nutr. 2009 Jul 27:1-10. [Epub ahead of print])
    View Abstract
  • A traditional rice and beans pattern is associated with metabolic syndrome in Puerto Rican older adults.
    (Noel SE, et al. J Nutr. 2009 Jul;139(7):1360-7. Epub 2009 May 20.)
    View Abstract
  • The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey.
    (Suh SY, et al. Metabolism. 2009 Jul 13. [Epub ahead of print])
    View Abstract
  • Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome.
    (Tulk HM, et al. Metabolism. 2009 Jul 20. [Epub ahead of print])
    View Abstract
  • Asymmetric dimethylarginine association with antioxidants intake in healthy young adults: a role as an indicator of metabolic syndrome features.
    (Puchau B, et al. Metabolism. 2009 Jul 6. [Epub ahead of print])
    View Abstract
  • Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome.
    (Sivaprakasapillai B, et al. Metabolism. 2009 Jul 14. [Epub ahead of print])
    View Abstract
  • Catabolism of lipoproteins and metabolic syndrome.
    (Therond P. Curr Opin Clin Nutr Metab Care. 2009 Jul;12(4):366-71. Review.)
    View Abstract
  • Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults.
    (Puchau B, et al. Eur J Clin Nutr. 2009 Jul;63(7):858-64. Epub 2008 Nov 5.)
    View Abstract
  • The metabolic syndrome of omega3-depleted rats. I. Liver data.
    (Malaisse WJ, et al. Int J Mol Med. 2009 Jul;24(1):111-23.)
    View Abstract
  • Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults.
    (Iqbal N, et al. Metab Syndr Relat Disord. 2009 Summer;7(2):143-50.)
    View Abstract
  • Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome.
    (Kaushik SV, et al. Diabetes Metab Res Rev. 2009 Jul;25(5):427-34.)
    View Abstract
  • The metabolic syndrome of omega3-depleted rats. II. Body weight, adipose tissue mass and glycemic homeostasis.
    (Sener A, et al. Int J Mol Med. 2009 Jul;24(1):125-9.)
    View Abstract
  • Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.
    (Mattson MP. Exp Gerontol. 2009 Jul 19. [Epub ahead of print])
    View Abstract

DRUG THERAPY

  • Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
    (Martínez Martín FJ. Expert Rev Cardiovasc Ther. 2009 Jul;7(7):863-9.)
    View Abstract
  • Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.
    (Toms TE, et al. Arthritis Res Ther. 2009 Jul 16;11(4):R110. [Epub ahead of print])
    View Abstract
  • The metabolic syndrome in overweight epileptic patients treated with valproic acid.
    (Verrotti A, et al. Epilepsia. 2009 Jul 20. [Epub ahead of print])
    View Abstract
  • Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.
    (Vergara-Rodriguez P, et al. Pharmacol Ther. 2009 Jul 30. [Epub ahead of print])
    View Abstract

EPIDEMIOLOGY

  • Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals.
    (Irie F, et al. Circ J. 2009 Jul 9. [Epub ahead of print])
    View Abstract
  • Relationship between brachial-ankle pulse wave velocity and cognitive function in an elderly community-dwelling population with metabolic syndrome.
    (Kim YS, et al. Arch Gerontol Geriatr. 2009 Jul-Aug;49(1):176-9. Epub 2008 Sep 10.)
    View Abstract
  • Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
    (Olynyk JK, et al. Am J Gastroenterol. 2009 Jul;104(7):1715-22. Epub 2009 Jun 2.)
    View Abstract
  • The association between changes in metabolic syndrome and changes in cost in a workplace population.
    (Schultz AB, et al. J Occup Environ Med. 2009 Jul;51(7):771-9.)
    View Abstract
  • Association of C-reactive protein and metabolic syndrome in a rural Chinese population.
    (Wen J, et al. Clin Biochem. 2009 Jul;42(10-11):976-83. Epub 2009 Apr 7.)
    View Abstract
  • A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population.
    (Oda E, et al. Environ Health Prev Med. 2009 Sep;14(5):284-91. Epub 2009 Jul 22.)
    View Abstract
  • Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria.
    (Hydrie MZ, et al. Metab Syndr Relat Disord. 2009 Summer;7(2):119-24.)
    View Abstract
  • Prevalence and associated factors for metabolic syndrome in Ttaiwanese hospital employees.
    (Ho HH, et al. Asia Pac J Public Health. 2009 Jul 22. [Epub ahead of print])
    View Abstract
  • Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
    (Hsu LA, et al. Metabolism. 2009 Jul;58(7):983-8.)
    View Abstract
  • Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals.
    (Lu L, et al. Diabetes Care. 2009 Jul;32(7):1278-83. Epub 2009 Apr 14.)
    View Abstract
  • Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects.
    (Yeung DC, et al. J Clin Endocrinol Metab. 2009 Jul;94(7):2531-6. Epub 2009 Apr 7.)
    View Abstract

EXERCISE / PHYSICAL ACTIVITY

  • Physical activity and risk of Metabolic Syndrome in an urban Mexican cohort.
    (Mendez-Hernandez P, et al. BMC Public Health. 2009 Jul 31;9(1):276. [Epub ahead of print])
    View Abstract
  • The association of levels of physical activity with metabolic syndrome in rural Australian adults.
    (Vaughan C, et al. BMC Public Health. 2009 Jul 31;9(1):273. [Epub ahead of print])
    View Abstract
GENETICS
  • Metabolic syndrome, diabetes and atherosclerosis: Influence of gene-environment interaction.
    (Andreassi MG. Mutat Res. 2009 Jul 10;667(1-2):35-43. Epub 2008 Nov 5.)
    View Abstract
  • Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.
    (Chien KL, et al. Transl Res. 2009 Sep;154(3):133-41. Epub 2009 Jul 9.)
    View Abstract
  • Associations of the estrogen receptors 1 and 2 gene polymorphisms with the metabolic syndrome in women.
    (Goulart AC, et al. Metab Syndr Relat Disord. 2009 Summer;7(2):111-7.)
    View Abstract
  • Variants in the insulin-degrading enzyme gene are associated with metabolic syndrome in Chinese elders.
    (Lu X, et al. Metabolism. 2009 Jul 8. [Epub ahead of print])
    View Abstract
  • Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome.
    (Ranjith N, et al. Metab Syndr Relat Disord. 2009 Jul 30. [Epub ahead of print])
    View Abstract
  • TRIB3 functional Q84R polymorphism is a risk factor for metabolic syndrome and carotid atherosclerosis.
    (Gong HP, et al. Diabetes Care. 2009 Jul;32(7):1311-3. Epub 2009 Apr 23.)
    View Abstract
  • Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal polish women.
    (Milewicz A, et al. Exp Clin Endocrinol Diabetes. 2009 Jul 16. [Epub ahead of print])
    View Abstract
  • Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice.
    (Inagaki T, et al. Genes Cells. 2009 Aug;14(8):991-1001. Epub 2009 Jul 15.)
    View Abstract
HYPERTENSION
  • Impaired atrial synchronicity in patients with metabolic syndrome associated with insulin resistance and independent of hypertension.
    (Li SH, et al. Hypertens Res. 2009 Jul 17. [Epub ahead of print])
    View Abstract
  • Association of the metabolic syndrome with pulmonary venous hypertension.
    (Robbins IM, et al. Chest. 2009 Jul;136(1):31-6. Epub 2009 Feb 2.)
    View Abstract
  • Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients.
    (Fortuño A, et al. J Hypertens. 2009 Jul;27(7):1420-30.)
    View Abstract

IMMUNOLOGY

  • The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy.
    (Hansen BR, et al. HIV Med. 2009 Jul;10(6):378-87. Epub 2009 Mar 26.)
    View Abstract
  • Chagas disease, adipose tissue and the metabolic syndrome.
    (Nagajyothi F, et al. Mem Inst Oswaldo Cruz. 2009 Jul;104(4):219-25.)
    View Abstract
  • Perspectives on adipose tissue, chagas disease and implications for the metabolic syndrome.
    (Nagajyothi F, et al. Interdiscip Perspect Infect Dis. 2009;2009:824324. Epub 2009 Jul 26.)
    View Abstract

INNOVATIVE TECHNIQUES / MODELING

  • Experimental rat models to study the metabolic syndrome.
    (Aleixandre de Artiñano A, et al. Br J Nutr. 2009 Jul 27:1-8. [Epub ahead of print])
    View Abstract
  • Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
    (Lee L, et al. Hepatology. 2009 Jul;50(1):56-67.)
    View Abstract
  • Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
    (Mizukawa M, et al. Hypertens Res. 2009 Jul;32(7):617-24. Epub 2009 May 22.)
    View Abstract
  • A new mouse model of metabolic syndrome and associated complications.
    (Wang Y, et al. J Endocrinol. 2009 Jul;202(1):17-28. Epub 2009 Apr 27.)
    View Abstract
  • Myocardial lysyl oxidase regulation of cardiac remodeling in a murine model of diet-induced metabolic syndrome.
    (Zibadi S, et al. Am J Physiol Heart Circ Physiol. 2009 Jul 10. [Epub ahead of print])
    View Abstract

KIDNEY DISEASE / RENAL FUNCTION

  • Impact of treating the metabolic syndrome on chronic kidney disease.
    (Agrawal V, et al. Nat Rev Nephrol. 2009 Jul 28. [Epub ahead of print])
    View Abstract
  • Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults.
    (Sookyoon Y, et al. Metabolism. 2009 Jul 15. [Epub ahead of print])
    View Abstract

LIVER DISEASE / LIVER FUNCTION

  • Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.
    (Graham RC, et al. J Pediatr Gastroenterol Nutr. 2009 Jul 28. [Epub ahead of print])
    View Abstract
  • The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis.
    (Lanthier N, et al. Curr Opin Clin Nutr Metab Care. 2009 Jul;12(4):404-11. Review.)
    View Abstract

METABOLIC SYNDROME IN WOMEN

  • Maternal substrate utilization programs the development of the metabolic syndrome in male mice exposed to high fat in utero.
    (Hartil K, et al. Pediatr Res. 2009 Jul 1. [Epub ahead of print])
    View Abstract
  • Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women.
    (Kilic S, et al. Climacteric. 2009 Jul 8:1-8. [Epub ahead of print])
    View Abstract
  • Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
    (Ni R, et al. Eur J Endocrinol. 2009 Jul 2. [Epub ahead of print])
    View Abstract
  • Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome.
    (Ozdemir S, et al. Int J Gynaecol Obstet. 2009 Jul;106(1):57-61. Epub 2009 Apr 25.)
    View Abstract
METABOLIC SYNDROME IN MEN
  • Men develop more intraabdominal obesity and signs of the metabolic syndrome after hyperalimentation than women.
    (Erlingsson S, et al. Metabolism. 2009 Jul;58(7):995-1001.)
    View Abstract
  • Bone mineral density in men with and without the metabolic syndrome.
    (Boyanov M, et al. Aging Male. 2009 Jul 24:1-4. [Epub ahead of print])
    View Abstract
  • Association of metabolic syndrome with smoking and alcohol intake in Japanese men.
    (Takeuchi T, et al. Nicotine Tob Res. 2009 Sep;11(9):1093-8. Epub 2009 Jul 13.)
    View Abstract
  • Prediction of metabolic syndrome by low serum testosterone levels in men: Results from the Study of Health in Pomerania.
    (Haring R, et al. Diabetes. 2009 Jul 6. [Epub ahead of print])
    View Abstract
  • Association of smoking status, weight change, and incident metabolic syndrome in men: a 3-year follow-up study.
    (Kim BJ, et al. Diabetes Care. 2009 Jul;32(7):1314-6. Epub 2009 Apr 23.)
    View Abstract
  • The emerging link between hypogonadism and metabolic syndrome.
    (Guay AT. J Androl. 2009 Jul-Aug;30(4):370-6. Epub 2008 Sep 4.)
    View Abstract

MISCELLANEOUS

  • Metabolic syndrome: perception or reality?
    (Lau DC. Curr Atheroscler Rep. 2009 Jul;11(4):264-71.)
    View Abstract

OBESITY

  • Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and cardiovascular parameters.
    (Pontiroli AE, et al. Cardiovasc Diabetol. 2009 Jul 20;8(1):37. [Epub ahead of print])
    View Abstract
  • Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome.
    (Yang G, et al. Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E211-24. Epub 2009 May 12.)
    View Abstract
PEDIATRICS
  • Metabolic syndrome and its association with white blood cell count in children and adolescents in Korea: The 2005 Korean National Health and Nutrition Examination Survey.
    (Lee YJ, et al. Nutr Metab Cardiovasc Dis. 2009 Jul 17. [Epub ahead of print])
    View Abstract
  • Screening of metabolic syndrome in obese children: A primary care concern.
    (Viggiano D, et al. J Pediatr Gastroenterol Nutr. 2009 Jul 8. [Epub ahead of print])
    View Abstract
  • Sex hormone-binding globulin levels and metabolic syndrome and its features in adolescents.
    (Oya ID, et al. Pediatr Diabetes. 2009 Jul 23. [Epub ahead of print])
    View Abstract
  • Prevalence of metabolic syndrome and associated risk factors in Brazilian schoolchildren.
    (Seki M, et al. Public Health Nutr. 2009 Jul;12(7):947-52. Epub 2008 Jul 24.)
    View Abstract
  • The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.
    (Barfield E, et al. J Pediatr Adolesc Gynecol. 2009 Jul 1. [Epub ahead of print])
    View Abstract

PSYCHOLOGICAL DISORDERS

  • No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study.
    (Hildrum B, et al. Acta Psychiatr Scand. 2009 Jul;120(1):14-22. Epub 2009 Dec 22.)
    View Abstract
  • Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study.
    (Carroll D, et al. Biol Psychiatry. 2009 Jul 1;66(1):91-3. Epub 2009 Apr 2.)
    View Abstract
  • Association of depressive symptoms and metabolic syndrome in men.
    (Viinamäki H, et al. Acta Psychiatr Scand. 2009 Jul;120(1):23-9. Epub 2009 Jan 7.)
    View Abstract

RISK FACTORS

  • Effect of heart rate on the risk of developing metabolic syndrome.
    (Inoue T, et al. Hypertens Res. 2009 Jul 31. [Epub ahead of print])
    View Abstract
  • Smoking cessation, alcohol intake and transient increase in the risk of metabolic syndrome among Japanese smokers at one health checkup institution.
    (Hishida A, et al. BMC Public Health. 2009 Jul 27;9:263.)
    View Abstract
  • Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
    (Zhang Y, et al. Endocrine. 2009 Jul 18. [Epub ahead of print])
    View Abstract
  • Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study.
    (Koskinen J, et al. Circulation. 2009 Jul 21;120(3):229-36. Epub 2009 Jul 6.)
    View Abstract
  • Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease.
    (Vlek AL, et al. J Vasc Surg. 2009 Jul;50(1):61-9. Epub 2009 Feb 15.)
    View Abstract
  • Inverse associations between muscle mass, strength, and the metabolic syndrome.
    (Atlantis E, et al. Metabolism. 2009 Jul;58(7):1013-22.)
    View Abstract
  • Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area.
    (Ayturk S, et al. Eur J Endocrinol. 2009 Jul 24. [Epub ahead of print])
    View Abstract
  • Metabolic syndrome in carbon disulfide-poisoned subjects in Korea: does chemical poisoning induce metabolic syndrome?
    (Jhun HJ, et al. Int Arch Occup Environ Health. 2009 Jul;82(7):827-32. Epub 2008 Oct 25.)
    View Abstract
  • Positive association between increased popliteal artery vessel wall thickness and generalized osteoarthritis: is OA also part of the metabolic syndrome?
    (Kornaat PR, et al. Skeletal Radiol. 2009 Jul 3. [Epub ahead of print])
    View Abstract
  • Association between thyroid hormones, insulin resistance, and metabolic syndrome.
    (Kumar HK, et al. Saudi Med J. 2009 Jul;30(7):907-11.)
    View Abstract
  • Airflow obstruction and the metabolic syndrome: the Guangzhou Biobank Cohort Study.
    (Lam KB, et al. Eur Respir J. 2009 Jul 2. [Epub ahead of print])
    View Abstract
  • Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome.
    (Lin CC, et al. Diabetes Res Clin Pract. 2009 Jul;85(1):24-9. Epub 2009 Apr 28.)
    View Abstract

SCREENING

  • Hypertensive waist: first step of the screening for metabolic syndrome.
    (Nita C, et al. Metab Syndr Relat Disord. 2009 Summer;7(2):105-10.)
    View Abstract

TREATMENT

  • Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
    (Raal FJ. Metab Syndr Relat Disord. 2009 Summer;7(2):83-8. Review.)
    View Abstract

Framingham Risk Assessment Tool
Estimates 10-year risk of developing hard CHD
> View Tool

Procam Risk Calculator
Estimates your risk of a heart attack (myocardial infarction) within the next 10 years based upon data of the PROCAM Study
> View Calculator


SCORE
(European High Risk Chart)

Estimates 10 year risk of fatal CVD in high risk regions of Europe by gender, age, systolic blood pressure, total cholesterol and smoking status.
> View Chart

UKPDS Risk Engine
The UKPDS Risk Engine is a type 2 diabetes specific risk calculator based on 53,000 patients years of data from the UK Prospective Diabetes Study, which also provides an approximate 'margin of error' for each estimate.
> View Risk Engine

Coordinated by Dr. Scott Grundy, Past-President of the IAS